Rare Disease Specialist

Founded in 1849, Pfizer Inc. began as a small chemistry enterprise built on the belief that scientific ingenuity can improve—and protect—human life. Today, as one of the world’s leading biopharmaceutical companies, Pfizer’s purpose is Breakthroughs that change patients’ lives : discovering, developing, and delivering medicines and vaccines that address unmet need, earn trust through quality and integrity, and reach patients through strong partnerships across the healthcare system. In a complex and rapidly evolving pharmaceutical landscape, our work is measured by one outcome - helping patients live longer, healthier lives . Rare Disease Hemophilia Sales Organization Mission & Impact Pfizer’s Rare Disease – Hemophilia Sales organization exists to help improve the lives of people living with hemophilia by connecting scientific innovation to the clinicians and systems that deliver care. We lead with integrity and patient need—promoting Pfizer Hemophilia therapies compliantly, helping customers understand appropriate use, and reducing access and care coordination barriers so more patients can start and stay on the right therapy. Our impact is better, more consistent outcomes for patients and a higher standard of care across the hemophilia community. Patient impact in rare disease: Support appropriate diagnosis, referral to Hemophilia Treatment Centers (HTCs) where applicable, initiation, and persistence by engaging hematologists, HTC multidisciplinary teams, and allied care partners involved in bleeding disorder management. Disease education grounded in evidence: Reinforce evidence-based value narratives using approved materials to support informed clinical decision-making in hemophilia. Coordinated care pathways & access: Partner across the matrix and with HTCs, specialty pharmacies, payers, and ancillary sites to simplify starts, reimbursement navigation, and continuity

Founded in 1849, Pfizer Inc. began as a small chemistry enterprise built on the belief that scientific ingenuity can improve—and protect—human life. Today, as one of the world’s leading biopharmaceutical companies, Pfizer’s purpose is Breakthroughs that change patients’ lives : discovering, developing, and delivering medicines and vaccines that address unmet need, earn trust through quality and integrity, and reach patients through strong partnerships across the healthcare system. In a complex and rapidly evolving pharmaceutical landscape, our work is measured by one outcome - helping patients live longer, healthier lives . Rare Disease Hemophilia Sales Organization Mission & Impact Pfizer’s Rare Disease – Hemophilia Sales organization exists to help improve the lives of people living with hemophilia by connecting scientific innovation to the clinicians and systems that deliver care. We lead with integrity and patient need—promoting Pfizer Hemophilia therapies compliantly, helping customers understand appropriate use, and reducing access and care coordination barriers so more patients can start and stay on the right therapy. Our impact is better, more consistent outcomes for patients and a higher standard of care across the hemophilia community. Patient impact in rare disease: Support appropriate diagnosis, referral to Hemophilia Treatment Centers (HTCs) where applicable, initiation, and persistence by engaging hematologists, HTC multidisciplinary teams, and allied care partners involved in bleeding disorder management. Disease education grounded in evidence: Reinforce evidence-based value narratives using approved materials to support informed clinical decision-making in hemophilia. Coordinated care pathways & access: Partner across the matrix and with HTCs, specialty pharmacies, payers, and ancillary sites to simplify starts, reimbursement navigation, and continuity

Pfizer US/PR Commercial Sales Founded in 1849, Pfizer Inc. began as a small chemistry enterprise built on the belief that scientific ingenuity can improve—and protect—human life. Today, as one of the world’s leading biopharmaceutical companies, Pfizer’s purpose is Breakthroughs that change patients’ lives : discovering, developing, and delivering medicines and vaccines that address unmet need, earn trust through quality and integrity, and reach patients through strong partnerships across the healthcare system. In a complex and rapidly evolving pharmaceutical landscape, our work is measured by one outcome - helping patients live longer, healthier lives . Rare Disease Hemophilia Sales Organization Mission & Impact Pfizer’s Rare Disease – Hemophilia Sales organization exists to help improve the lives of people living with hemophilia by connecting scientific innovation to the clinicians and systems that deliver care. We lead with integrity and patient need—promoting Pfizer Hemophilia therapies compliantly, helping customers understand appropriate use, and reducing access and care coordination barriers so more patients can start and stay on the right therapy. Our impact is better, more consistent outcomes for patients and a higher standard of care across the hemophilia community. Patient impact in rare disease: Support appropriate diagnosis, referral to Hemophilia Treatment Centers (HTCs) where applicable, initiation, and persistence by engaging hematologists, HTC multidisciplinary teams, and allied care partners involved in bleeding disorder management. Disease educ

Founded in 1849, Pfizer Inc. began as a small chemistry enterprise built on the belief that scientific ingenuity can improve—and protect—human life. Today, as one of the world’s leading biopharmaceutical companies, Pfizer’s purpose is Breakthroughs that change patients’ lives : discovering, developing, and delivering medicines and vaccines that address unmet need, earn trust through quality and integrity, and reach patients through strong partnerships across the healthcare system. In a complex and rapidly evolving pharmaceutical landscape, our work is measured by one outcome - helping patients live longer, healthier lives . Rare Disease Hemophilia Sales Organization Mission & Impact Pfizer’s Rare Disease – Hemophilia Sales organization exists to help improve the lives of people living with hemophilia by connecting scientific innovation to the clinicians and systems that deliver care. We lead with integrity and patient need—promoting Pfizer Hemophilia therapies compliantly, helping customers understand appropriate use, and reducing access and care coordination barriers so more patients can start and stay on the right therapy. Our impact is better, more consistent outcomes for patients and a higher standard of care across the hemophilia community. Patient impact in rare disease: Support appropriate diagnosis, referral to Hemophilia Treatment Centers (HTCs) where applicable, initiation, and persistence by engaging hematologists, HTC multidisciplinary teams, and allied care partners involved in bleeding disorder management. Disease education grounded in evidence: Reinforce evidence-based value narratives using approved materials to support informed clinical decision-making in hemophilia. Coordinated care pathways & access: Partner across the matrix and with HTCs, specialty pharmacies, payers, and ancillary sites to simplify starts, reimbursement navigation, and continuity

Founded in 1849, Pfizer Inc. began as a small chemistry enterprise built on the belief that scientific ingenuity can improve—and protect—human life. Today, as one of the world’s leading biopharmaceutical companies, Pfizer’s purpose is Breakthroughs that change patients’ lives : discovering, developing, and delivering medicines and vaccines that address unmet need, earn trust through quality and integrity, and reach patients through strong partnerships across the healthcare system. In a complex and rapidly evolving pharmaceutical landscape, our work is measured by one outcome - helping patients live longer, healthier lives . Rare Disease Sales Organization Mission & Impact Pfizer’s Rare Disease – Rare Cardiac Sales organization exists to help improve the lives of people living with serious rare cardiac conditions by connecting scientific innovation to the clinicians and systems that deliver care. We lead with integrity and patient need— advancing disease and product education grounded in robust clinical evidence , promoting Pfizer Rare Cardiac therapies compliantly, and supporting healthcare professionals’ understanding of appropriate patient identification and use based on approved indications. Through evidence‑based scientific exchange, we help reduce access, diagnostic, and workflow barriers so more patients can start and stay on the right therapy. Our impact is more informed clinical decision ‑ making, improved consistency of care, and better outcomes for patients , contributing to a higher standard of care across the rare cardiac community. Role Summary The Rare Disease – Rare Cardiac, Senior Health & Science Specialist is a field-based specialty sales role responsible for driving the growth of Rare Cardiac products through compliant, strategic relationships within assigned accounts. This role partners with Therapeutic Area Specialists and Key

Why Patients Need You Everything we do, every day, is in line with an unwavering commitment to the quality and the delivery of safe and effective products to patients. Our science and risk-based compliant quality culture is innovative and customer oriented. Whether you are involved in manufacturing, testing, or compliance, your contribution will directly impact patients. What You Will Achieve The Rare Disease, Area Rare Cardiac Specialists (ARCS), will target health care providers (HCPs), spanning general cardiology, across IDN/Health Systems, group practice accounts, other. In this role, this individual will primarily be responsible for the execution of ATTR-CM disease awareness with appropriate customer stakeholders, working closely with the Cardiac Account Specialist (CAS) to ensure seamless customer interactions throughout the patient journey. The role will report into the Area Business Manager (ABM). The Area Rare Cardiac Specialists (ARCS) will demonstrate strong business acumen, and an expert understanding of the complexities associated with their local healthcare ecosystem. The incumbent will utilize this knowledge to develop in-depth sales business plans; and in collaboration with other customer facing colleagues (i.e. CAS), the individual will then execute upon those plans to accelerate new patient starts through increased disease state awareness in the territories (CAS) they overlay. To accomplish these goals, the individual will effectively utilize approved marketing resources to educate customers and build meaningful relationships to drive patient recognition. The Area Rare Cardiac Specialists (ARCS) must strictly abide by all company policies and applicable government regulations. How You Will Achieve It Account Planning Collaboration Prioritize customers opportunities and projects to maximize imp